Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Related ROP
Weak Guidance To Continue This Earnings Season - Economic Highlights
UPDATE: Roper Industries Posts Upbeat Q3 Earnings
Related ATRC
AtriCure Completes Enrollment In Post Approval Study For The Synergy Ablation System
Liberator Medical Holdings (LBMH) Jumps: Stock Gains 6.3% - Tale of the Tape

Analysts at Citigroup upgraded Roper Industries (NYSE: ROP) from “neutral” to “buy.” Roper Industries' shares closed at $107.69 yesterday. Roper Industries' PEG ratio is 1.52.

Analysts at Piper Jaffray upgraded AtriCure (NASDAQ: ATRC) from “neutral” to “overweight.” AtriCure's shares closed at $6.43 yesterday. AtriCure's trailing-twelve-month revenue is $68.65 million.

Analysts at Wells Fargo upgraded Heartland Payment Systems (NYSE: HPY) from “market perform” to “outperform.” Heartland Payment's stock closed at $27.02 yesterday. Heartland Payment's trailing-twelve-month ROE is 26.79%.

Analysts at Mizuho upgraded Cepheid (NASDAQ: CPHD) from “neutral” to “buy.” Cepheid's shares closed at $28.72 yesterday. Cepheid had $103.52 million in total cash for the latest quarter.

Latest Ratings for ROP

DateFirmActionFromTo
Nov 2014RBC CapitalInitiates Coverage onOutperform
Oct 2014BarclaysMaintainsOverweight
Jul 2014BarclaysMaintainsOverweight

View More Analyst Ratings for ROP
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ATRC + CPHD)

Around the Web, We're Loving...

Get Benzinga's Newsletters